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The International Rare Donor Panel (IRDP) has been 
in existence for almost 50 years and is now a worldwide 
collaboration involving 27 countries, with approximately 8000 
rare donors listed. The Red Cell Reference Department of the 
International Blood Group Reference Laboratory (IBGRL) 
has compiled and maintained the panel since it began. The 
purpose of the panel is to locate and facilitate the exchange of 
rare blood between countries, when blood cannot be sourced 
nationally for a specified patient.
History
The pioneering work for the organization and compilation 
of the IRDP was carried out in the early to mid 1960s. The 
act of exchanging rare blood between countries was in place 
prior to that, however, as evidenced in The Lister Institute 
annual report of 1957, which in part describes highlights of 
the activities of the IBGRL and states:
[Dr. Parkin’s] previous discovery of a family in England 
and Ireland with the exceedingly rare “Bombay” blood 
group (apparent red-cell group O, with anti-O in serum) 
made it possible for the laboratory to arrange for the 
transfusion of a baby in Holland with blood from one of 
the only two potential donors in Europe.1
In 1964 the then-director of the IBGRL, Dr Arthur E. 
Mourant, presented a proposal for the organization of an 
international panel of blood donors of rare types at the General 
Assembly of the International Society of Blood Transfusion 
(ISBT) in Stockholm.2 Following this, in 1965, the IRDP was 
established as an ISBT initiative in collaboration with the World 
Health Organization. The purpose of the panel was to locate 
and facilitate exchange of rare blood units between countries 
for patients in need. The organization and maintenance of the 
panel were allocated to the IBGRL, and the inaugural meeting 
of the newly formed ISBT Advisory Committee for the IRDP 
took place on February 9, 1966, at the IBGRL in London.3 It 
was decided at this meeting that the panel should consist of 
two categories: the first category included group O donors 
whose red blood cells (RBCs) lacked antigens to a range of 
antibodies commonly encountered, therefore making them 
useful for transfusion to patients with multiple antibodies; 
the second category included donors whose RBCs lacked a 
high-prevalence antigen.3 The first panel was published in 
1968 and consisted of almost 300 donors from 10 countries.4 
The panel was typed and copies were distributed by mail, 
accompanied by an introductory letter (Fig. 1). 
Since then, the panel has organically adapted with 
advances in technology and the discovery of more and more 
blood groups. In 1981, the panel was compiled on a computer for 
Fig. 1 Accompanying letter to the first edition of the International 
Rare Donor Panel.
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the first time, although the technology only had the capability 
to enter and print information in capital letters, which was 
not ideal when dealing with RBC antigens. To deal with the 
issue, the word “little” was used to denote when a lowercase 
letter was indicated (Fig. 2). Around this time, the decision 
was made to remove the first of the original two categories of 
donors from the IRDP, since donors lacking common antigens 
could generally be provided locally. The panel was printed on 
large reams of paper (Fig. 2) and continued to be sent out by 
mail. When the 1985 panel was compiled and distributed in 
this way, it consisted of approximately 1500 donors from 22 
countries and was sent to 110 blood centers around the world. 
In 1991, the panel was compiled on an in-house computer 
at IBGRL (Fig. 3), which made adding and deleting donors 
a more continuous process. It was at this time that modem 
access was made available, which meant 24-hour password-
protected access to the panel was now possible for those blood 
centers with modem capability. Then, in 1999, the panel was 
made accessible via the Internet. Information technology 
development and the beginning of the Internet age changed the 
usability of the IRDP significantly, although it was probably 
not exactly what Dr. Mourant had envisaged in 1964 when he 
wrote,
The scheme would be organized by an International 
Central Office and Laboratory, which would collate, edit, 
and publish a list of donors of rare types. . . . This proposal 
does not exclude ultimate transfer of lists to mechanical 
or electronic selector systems, but I am sure that we must 
begin with printed or stencilled lists.2
Table 1. Rare donor listings of the International Rare Donor Panel, 2015
Number of donors
>500 250–500 100–249 50–99 25–49 10–24 5–9 0–4
Fy(a–b–) S–s–U– Js(a+b–) K0 Ge− RH:–51 (MAR–) SC:–1 Cr(a–)
Jr(a–) Co(a–b+) Jk(a–b–) Oh(Bombay) LW(a–b+) CDE/CDE (RzRz) Ok(a–) K11–
Di(b–) Yt(a–) I– p Gy(a–) JMH– En(a–)
Lu(a+b–) Vel– D–– S–s–U+var Pk At(a–) Er(a–)
Lu(a–b–) Rhnull In(b–) RH:–46 (Sec–)






Fig. 2 Front page of the 1985 printed International Rare Donor Panel.
Fig. 3 Compiling the International Rare Donor Panel on a computer 
at the International Blood Group Reference Laboratory in the early 
1990s.
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In 2007, a new IRDP database was developed by the 
National Health Service (NHS) Blood and Transplant Center 
for IBGRL and included functionality to search on multiple 
criteria, including ABO group and other antigen-negative 
requirements in addition to the rare phenotype. This database 
has been updated periodically and remains in use today 
(Fig. 4).
Figures 5–8 provide additional information from the early 
days of the IRDP. 
The IRDP Today
Currently, the IRDP has approximately 8000 donors 
listed from 27 countries.5 The IRDP is only intended for 
use when blood cannot be sourced nationally; therefore, the 
rarities listed represent those that are the hardest to find in 
most populations. Some categories are still rarer than others, 
as shown in Table 1. In addition to individually listed donors, 
the IRDP includes the frozen inventories of blood banks from 
around the world. A number of these contributing institutions 
choose only to list the number of frozen units according to 
ABO and rarity; therefore, the number of actual donors will be 
greater in the respective categories.
The IBGRL, now located in Bristol at the NHS Blood and 
Transplant Filton center, continues to compile and maintain 
the IRDP. The role of the IBGRL is to receive rare donor lists, 
provided by the contributing countries, and update the IRDP 
database according to the additions and/or deletions provided 
on the lists. Some contributors send samples to IBGRL for 
confirmatory testing of newly identified donors, although 
this is not a requirement for inclusion of a donor to the panel. 
Donors are assigned a unique number by their contributing 
country and are listed by this number on the IRDP; therefore, 
Fig. 4 Searching the International Rare Donor Panel in 2015.
Fig. 5 Arthur E. Mourant circa 1964.
Fig. 6 International Society of Blood Transfusion news bulletin, 1965.
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no personal donor data are held in the database. Most IRDP 
contributors maintain a national donor registry, but in 
countries where a national registry is not established, there may 
be a number of individual contributing institutions from the 
same country. All contributors are required to provide IBGRL 
with any amendments to their designated contact personnel 
details. This step is very important to ensure the appropriate 
person/department can always be contacted to inquire about 
rare donor availability. The IBGRL makes all this information 
available via the Internet, and authorized users can access the 
panel at https://rare.blood.co.uk/RareDonor/Login/Default.
aspx. Access requests can be made by medical professionals, 
who may be required to source rare blood for clinical use only. 
All access requests should be made to the IBGRL by e-mailing 
rare.donor@nhsbt.nhs.uk. The staff of the IBGRL Red Cell 
Reference Department is also available to carry out searches 
when required, and search requests can be sent to the same 
e-mail address.
When a search of the IRDP has been carried out and 
possible rare donors identified, the requestor is provided with 
the contact details for the relevant contributing institutions. 
It is then the responsibility of the requestor to contact the 
contributors to inquire about donor availability and to discuss 
the logistics associated with obtaining blood from another 
country, including mandatory testing practice, shipment, 
customs requirements, and price. The IBGRL works closely 
with the ISBT Rare Donor Working Party to ensure that the 
IRDP functions as optimally as possible. An “International 
Shipment of Rare Blood Response Form” was devised by the 
Working Party to capture useful information regarding the 
outcome of any rare blood shipments that have occurred as 
a result of searching the IRDP.5 This information helps us to 
understand rare blood demand and to ensure that the IRDP 
process runs without problems; it also helps to capture any 
logistical issues that may need addressing by the Working 
Party.
The Future of the IRDP
It is important that the IRDP evolves with the changing 
demands for blood of rare types. These changes not only 
coincide with discovery of new blood groups, but also with 
scientific and information technology developments. DNA-
based testing to find rare donors is already being used in 
some countries,6–8 and it is likely that the potential to scale 
up rare donor screening will be realized as high-throughput 
genotyping platforms become more economical. This scenario 
will bring new challenges for the IRDP. The IRDP database 
Fig. 7 International Blood Group Reference Laboratory visitors 
book at 1966 International Rare Donor Panel advisory meeting.
Fig. 8 First page of the International Rare Donor Panel advisory 
minutes.
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is currently undergoing an upgrade that will provide new 
functionality to enable remote upload of donor lists and updates 
to contributor contact details.5 This functionality will make the 
panel maintenance more efficient, and it is hoped that more 
regular updates will be possible.
Summary
Over the past 50 years, the IRDP has evolved and 
developed to meet international rare blood needs. Although 
the definition of a rare donor has changed since the early days 
of the panel, the purpose of the IRDP has always remained the 
same: to locate and facilitate exchange of rare blood for patients 
in need. It is important to remember that rare blood is required 
rarely, but when it is needed, the worldwide collaboration of 
the IRDP ensures that every effort can be made to find blood 
for patients with even the rarest of blood types. Although it 
is difficult to predict what the next 50 years might bring, no 
matter what format the IRDP takes, the purpose of the panel 
is unlikely to change.
Acknowledgments
The author would like to thank all those who contribute to 
the IRDP for the wonderful worldwide collaboration. Most of 
all, we must thank the rare donors of the IRDP; their selfless 
generosity to save the lives of others, regardless of where they 
may be in the world, is remarkable.
References
 1. The Lister Institute annual report. Bushey, UK: The Lister 
Institute, 1957.
 2. Mourant AE. The establishment of an international panel of 
blood donors of rare types. Vox Sang 1965;10:129–32.
 3. ISBT Advisory Committee for the International Panel of Donors 
of Rare Types. Minutes of a meeting held at the Blood Group 
Reference Laboratory. [Minutes of meeting held 9 February.] 
London, 1966 (Unpublished).
 4. Anstee D, Levene C, Mallory D, et al. Rare blood: an ISBT 
working party report on rare blood donors. Vox Sang 
1999;77:58–62.
 5. Nance S, Scharberg EA, Thornton N, Yahalom V, Sareneva I, 
Lomas-Francis C. International rare donor panels: a review. 
Vox Sang 2015. doi: 10.1111/vox.12357. 
 6. Jungbauer C. Molecular bases and genotyping for rare blood 
types. Transfus Med Hemother 2009;36:213–8.
 7. Revelli N, Villa MA, Paccapelo C, et al.  The Lombardy Rare 
Donor Programme. Blood Transfus 2014;12(Suppl 1):s249–55. 
 8. Arnoni CP, Latini FR, Muniz JG, et al. A simple approach 
to screen rare donors in Brazil. Immunohematology 
2015;31:20–3.
Nicole M. Thornton, MSc, Head of Red Cell Reference, International 
Blood Group Reference Laboratory, Red Cell Reference Department, 
NHS Blood and Transplant, 500 North Bristol Park, Northway, 
Filton, Bristol BS34 7QH, UK, nicole.thornton@nhsbt.nhs.uk.
